Prophylactic Treatment with a G Glycoprotein Monoclonal Antibody Reduces Pulmonary Inflammation in Respiratory Syncytial Virus (RSV)-Challenged Naïve and Formalin-Inactivated RSV-Immunized BALB/c Mice

Eitemau Tebyg

• Decrease in Formalin-Inactivated Respiratory Syncytial Virus (FI-RSV) Enhanced Disease with RSV G Glycoprotein Peptide Immunization in BALB/c Mice
  gan: Rey, Gertrud U., et al.
  Cyhoeddwyd: (2013)
• Combination Therapy Using Monoclonal Antibodies against Respiratory Syncytial Virus (RSV) G Glycoprotein Protects from RSV Disease in BALB/c Mice
  gan: Caidi, Hayat, et al.
  Cyhoeddwyd: (2012)
• Treatment with respiratory syncytial virus G glycoprotein monoclonal antibody or F(ab′)(2) components mediates reduced pulmonary inflammation in mice
  gan: Miao, Congrong, et al.
  Cyhoeddwyd: (2009)
• Anti-respiratory syncytial virus (RSV) G monoclonal antibodies reduce lung inflammation and viral lung titers when delivered therapeutically in a BALB/c mouse model
  gan: Caidi, Hayat, et al.
  Cyhoeddwyd: (2018)
• Cytotoxic T-Lymphocyte Precursor Frequencies in BALB/c Mice after Acute Respiratory Syncytial Virus (RSV) Infection or Immunization with a Formalin-Inactivated RSV Vaccine
  gan: Tripp, Ralph A., et al.
  Cyhoeddwyd: (1998)